Raman and solid state 13C-NMR investigation of the structure of the 1: 1 amorphous piroxicam: β-Cyclodextrin inclusion compound

Biospectroscopy

Volumn 5, Issue 4, 1999, Pages 243-251

  Redenti, Enrico ^a   Zanol, Margherita ^a   Ventura, Paolo ^a   Fronza, Giovanni ^b   Comotti, Angiolina ^c   Taddei, Paola ^d   Bertoluzza, Alessandro ^d  

^a CHIESI FARMACEUTICI S P A   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Amorphous state; Inclusion complexes; NIR FT Raman; Piroxicam; Polymorphous; Solid state 13C NMR; cyclodextrin

Indexed keywords

BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; CARBON; CYCLODEXTRIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ARTICLE; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAMAN SPECTROMETRY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-CYCLODEXTRINS; CARBON ISOTOPES; CYCLODEXTRINS; MAGNETIC RESONANCE SPECTROSCOPY; PIROXICAM; SPECTRUM ANALYSIS, RAMAN;

EID: 0032617682     PISSN: 10754261     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6343(1999)5:4<243::AID-BSPY5>3.0.CO;2-C     Document Type: Article

References (28)

1. Frömming, K. H.; Szejtli, J. Cyclodextrins in Pharmacy; Kluwer Academic Publishers: Dordrecht, 1994.
2. Lombardino, J. G.; Wiseman, E. H.; Chiaini, J. J Med Chem 1973, 16, 493-496.
3. Chiesi Villa, A.; Rizzoli, C.; Amari, G.; Delcanale, M.; Redenti, E.; Ventura, P. Supramol Chem 1998, 10, 111-119.
4. Szejtli, J. Cyclodextrins and Their Inclusion Complexes; Akadémiai Kiado; Budapest, 1982; p. 116.
5. Bertoluzza, A.; Rossi, M.; Taddei, P.; Redenti, E.; Zanol, M.; Ventura, P. "FT-Raman and FT-IR Studies of 1 : 2.5 Piroxicam: β-Cyclodextrin Inclusion Compound," XXIV European Congress on Molecular Spectroscopy, Book of Abstracts; ICT Press: Praha, August 23-28, 1998; p. 317/D108;
6. J Mol Struct, accepted.
7. Opella, S. J.; Frey, M. H. J Am Chem Soc 1979, 101, 5854-5856.
8. Earl, W. L.; Vanderhart, D. L. J Magn Reson 1982, 48, 35-54.
9. Bordner, J.; Hammen, P. D.; Whipple, E. B. J Am Chem Soc 1989, 111, 6572-6578.
10. Geckle, M.; Rescek, D. M.; Whipple, E. B. Magn Reson Chem 1989, 27, 150-154.
11. Kozjeck, F.; Golic, L.; Zupet, P.; Palka, E.; Vodopivec, P.; Japelj, M. Acta Pharm Jugosl 1985, 35, 275-281.
12. Mihalic, M.; Hofman, H.; Kuftinec, J.; Blazevic, N.; Zimic, M. "Piroxicam," in Analytical Profiles of Drug Substances, vol. 15; ed. by Florey, K., Academic Press: Orlando, FL 1986; pp. 509-531.
13. Vrecer, F.; Srcic, S.; Smid-Korbar, J. J Int J Pharm 1991, 68, 35-41.
14. Reck, G.; Dietz, G.; Laban, G.; Gunther, W.; Bannier, G.; Hohne, E. Pharmazie 1988, 43, 477-481.
15. Bordner, J.; Richards, J. A.; Weeks, P.; Whipple, E. B. Acta Crystallogr 1984, C40, 989-990.
16. Santi, E.; Torre, M. H.; Kremer, E.; Etcheverry, S. B.; Baran, E. J. Vib Spectros 1993, 5, 285-293.
17. Cini, R.; Giorgi, G.; Cinquantini, A.; Rossi, C.; Sabat, M. Inorg Chem 1990, 29, 197-200.
18. Dollish, F. R.; Fateley, W. G.; Bentley, F. F. Characteristic Raman Frequencies of Organic Compounds; Wiley: New York, 1973.
19. George, W. O.; Robinson, F. V. J Chem Soc (A) 1968, 1950-1968.
20. Spinner, E. J Chem Soc 1962, 3119-3127.
21. Wiseman, E. H.; Chang, Y. H.; Lombardino, J. C. Arzneim-Forsch 1976, 26, 1300-1303.
22. Bernhard, E.; Zimmermann, F. Arzneim-Forsch 1984, 34, 647-648.
23. Fyfe, C. A. Solid State NMR for Chemists; CFC Press: Guelph, Ontario, 1983.
24. Inoue, Y. Ann Rep NMR Spec 1993, 27, 59-101.
25. Breitmaier, E.; Voelter, W. Carbon-13 NMR Spectroscopy; VCH Publishers: Weinheim, Germany, 1989; pp. 285-286.
26. Opella, S. J.; Exem, J. G.; Frey, M. H.; Cross, T. A. Phil Trans R Soc Lond A 1984, 299, 665-683.
27. Balimann, G. E.; Groombridge, C. J.; Harris, R. K.; Packer, K. J.; Say, B. J.; Tanner, F. S. Phil Trans R Soc Lond Ser A 1981, 299, 643-663.
28. Piel, G.; Pirotte, B.; Delneuville, I.; Neven, P.; Llabrs, G.; Delarge, J.; Delattre, L. J Pharm Sci 1997, 86, 475-480.